BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2918 related articles for article (PubMed ID: 32203549)

  • 1. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
    Yang S; Pudasaini R; Zhi H; Wang L
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke.
    Yuan S; Tang B; Zheng J; Larsson SC
    Ann Neurol; 2020 Dec; 88(6):1229-1236. PubMed ID: 32981134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
    Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
    Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
    PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
    Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
    EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
    Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
    Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
    Georgakis MK; Malik R; Anderson CD; Parhofer KG; Hopewell JC; Dichgans M
    Brain; 2020 Feb; 143(2):597-610. PubMed ID: 31968102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian randomization of blood lipids for coronary heart disease.
    Holmes MV; Asselbergs FW; Palmer TM; Drenos F; Lanktree MB; Nelson CP; Dale CE; Padmanabhan S; Finan C; Swerdlow DI; Tragante V; van Iperen EP; Sivapalaratnam S; Shah S; Elbers CC; Shah T; Engmann J; Giambartolomei C; White J; Zabaneh D; Sofat R; McLachlan S; ; Doevendans PA; Balmforth AJ; Hall AS; North KE; Almoguera B; Hoogeveen RC; Cushman M; Fornage M; Patel SR; Redline S; Siscovick DS; Tsai MY; Karczewski KJ; Hofker MH; Verschuren WM; Bots ML; van der Schouw YT; Melander O; Dominiczak AF; Morris R; Ben-Shlomo Y; Price J; Kumari M; Baumert J; Peters A; Thorand B; Koenig W; Gaunt TR; Humphries SE; Clarke R; Watkins H; Farrall M; Wilson JG; Rich SS; de Bakker PI; Lange LA; Davey Smith G; Reiner AP; Talmud PJ; Kivimäki M; Lawlor DA; Dudbridge F; Samani NJ; Keating BJ; Hingorani AD; Casas JP
    Eur Heart J; 2015 Mar; 36(9):539-50. PubMed ID: 24474739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
    Liang Z; Zhao L; Lou Y; Liu S
    QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.
    Li MY; Kwok MK; Schooling CM
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
    Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
    JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study.
    Huang X; Zhao JV
    Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
    Chasman DI; Paré G; Zee RY; Parker AN; Cook NR; Buring JE; Kwiatkowski DJ; Rose LM; Smith JD; Williams PT; Rieder MJ; Rotter JI; Nickerson DA; Krauss RM; Miletich JP; Ridker PM
    Circ Cardiovasc Genet; 2008 Oct; 1(1):21-30. PubMed ID: 19802338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives.
    Richardson TG; Wang Q; Sanderson E; Mahajan A; McCarthy MI; Frayling TM; Ala-Korpela M; Sniderman A; Smith GD; Holmes MV
    Lancet Healthy Longev; 2021 Jun; 2(6):e317-e326. PubMed ID: 34729547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage.
    Falcone GJ; Kirsch E; Acosta JN; Noche RB; Leasure A; Marini S; Chung J; Selim M; Meschia JF; Brown DL; Worrall BB; Tirschwell DL; Jagiella JM; Schmidt H; Jimenez-Conde J; Fernandez-Cadenas I; Lindgren A; Slowik A; Gill D; Holmes M; Phuah CL; Petersen NH; Matouk Md CN; Gunel M; Sansing L; Bennett D; Chen Z; Sun LL; Clarke R; Walters RG; Gill TM; Biffi A; Kathiresan S; Langefeld CD; Woo D; Rosand J; Sheth KN; Anderson CD;
    Ann Neurol; 2020 Jul; 88(1):56-66. PubMed ID: 32277781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and sudden sensorineural hearing loss: A bidirectional two-sample Mendelian randomization analysis.
    Pu K; Li L; Qiu Y; Song H
    Auris Nasus Larynx; 2024 Apr; 51(2):365-370. PubMed ID: 37993362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
    Burgess S; Harshfield E
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 146.